GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,364.00
Bid: 4,387.00
Ask: 4,388.00
Change: -40.00 (-0.91%)
Spread: 1.00 (0.023%)
Open: 4,420.00
High: 4,448.00
Low: 4,364.00
Prev. Close: 4,404.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restatement of results for new reporting structure

4 Jun 2021 13:13

RNS Number : 9165A
Croda International PLC
04 June 2021
 

Regulatory News Announcement

4 June 2021

 

Croda International Plc

Restatement of results for new reporting structure

 

Croda International Plc ('Croda' or 'the Group') announced in November 2020 that from 2021 it would amend its reporting structure to report under four sectors - Consumer Care, Life Sciences, Performance Technologies and Industrial Chemicals.

 

In advance of its half year results on 27 July 2021, the Group is publishing restated segmental results for half year 2020 to provide a like-for-like comparator.

 

Consumer Care comprises the Personal Care sector, including Iberchem, a customer previously reported within Life Sciences, and the Home Care business unit from Performance Technologies.

 

The table below sets out the new structure, showing half year 2020 results as previously reported and the results for the same period restated to reflect the new structure. There is no impact from the Group's acquisitions of Avanti and Iberchem as they were both completed in the second half of 2020.

Sales

Adjusted operating profit*

Half year ended 30 June 2020

Reported currency

 

As

reported

£m

Restated

£m

As

reported

£m

Restated

£m

Consumer Care

226.7

251.1

68.9

73.7

Life Sciences

182.9

179.8

59.4

57.8

Performance Technologies

216.3

195.0

32.7

29.5

Industrial Chemicals

47.0

47.0

0.6

0.6

Group

672.9

672.9

161.6

161.6

 

* Adjusted operating profit is stated before exceptional items, acquisition costs and amortisation of intangible assets arising on acquisition.

 

Further information

 

David Bishop, Director of Investor Relations and Corporate Affairs: +44 7823 874428

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAAKLEENFEFA
Date   Source Headline
8th Nov 20139:52 amRNSDirector/PDMR Shareholding
7th Nov 20132:07 pmRNSDirector/PDMR Shareholding
5th Nov 20137:00 amRNSCapital Markets Day
1st Nov 201312:24 pmRNSDirector/PDMR Shareholding
31st Oct 20137:00 amRNSInterim Management Statement
30th Oct 20135:25 pmRNSHolding(s) in Company
11th Oct 20134:38 pmRNSDirector/PDMR Shareholding
7th Oct 20131:06 pmRNSHolding(s) in Company
4th Oct 201312:01 pmRNSDirector/PDMR Shareholding
19th Sep 20131:51 pmRNSDirector/PDMR Shareholding
11th Sep 20131:59 pmRNSDirector/PDMR Shareholding
13th Aug 201311:43 amRNSDirector/PDMR Shareholding
6th Aug 20139:27 amRNSAcquisition
5th Aug 20139:59 amRNSHolding(s) in Company
1st Aug 20132:12 pmRNSHolding(s) in Company
29th Jul 20137:00 amRNSAcquisition
26th Jul 20138:33 amRNSDirector/PDMR Shareholding
24th Jul 20132:44 pmRNSDirector/PDMR Shareholding
23rd Jul 20137:00 amRNSInterim Results 2013
17th Jul 20139:15 amRNSHolding(s) in Company
15th Jul 20133:58 pmRNSHolding(s) in Company
11th Jul 20134:43 pmRNSDirector/PDMR Shareholding
1st Jul 20139:46 amRNSHolding(s) in Company
28th Jun 20139:32 amRNSHolding(s) in Company
11th Jun 20135:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20133:57 pmRNSDirector/PDMR Shareholding
24th May 20137:00 amRNSAcquisition
22nd May 20132:58 pmRNSDirector/PDMR Shareholding
13th May 20134:35 pmRNSDirector/PDMR Shareholding
1st May 20134:30 pmRNSDirector/PDMR Shareholding
30th Apr 20134:42 pmRNSDirector/PDMR Shareholding Replacement
30th Apr 20134:16 pmRNSDirector/PDMR Shareholding
30th Apr 20138:23 amRNSHolding(s) in Company
29th Apr 201312:20 pmRNSHolding(s) in Company
25th Apr 20133:40 pmRNSResult of AGM
25th Apr 20137:00 amRNSInterim Management Statement
12th Apr 20133:11 pmRNSDirector/PDMR Shareholding
12th Apr 20137:30 amRNSTransaction in Own Shares
28th Mar 201310:14 amRNSDirector/PDMR Shareholding
22nd Mar 20135:30 pmRNSAnnual Financial Report
21st Mar 20137:10 amRNSDirector Declaration
14th Mar 201311:42 amRNSDirector/PDMR Shareholding
12th Mar 20135:35 pmRNSDirector/PDMR Shareholding
26th Feb 20132:34 pmRNSDirector/PDMR Shareholding
26th Feb 20137:00 amRNSPreliminary Results
13th Feb 20139:12 amRNSDirector/PDMR Shareholding
14th Jan 20132:00 pmRNSAcquisition of Innovachem
24th Dec 201211:33 amRNSDirector/PDMR Shareholding
12th Dec 201210:17 amRNSDirector/PDMR Shareholding
29th Nov 20125:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.